Clinical Trial Update: Short-Term Alpha Lipoic Acid Therapy for Prevention of Contrast-induced Acute Kidney Injury and Endothelial Dysfunction in Type 2 Diabetes [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update investigates short-term alpha-lipoic acid to prevent contrast-induced acute kidney injury and endothelial dysfunction in patient…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endothelial Dysfunction
• Kidney Injury
• Type 2 Diabetes Mellitus

Drugs mentioned

• Alpha Lipoic Acid (alpha-lipoic acid)

Snippet

Sponsor: Xiang Guang-da | Conditions: Acute Kidney Injury, The Changes of Plasma Creatinine | Phase 4 | Status: UNKNOWN